Infections in immunosuppressed travellers with autoimmune inflammatory diseases-a narrative review and advice for clinical practice.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34022043.
- Also identified by DOI 10.1093/rheumatology/keab445 and PMC identifier 8409992.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The management of autoimmune, inflammatory diseases has been revolutionized by biologic therapies. A beneficial consequence of better disease control is that more patients are well enough to travel the world. There is now a class of traveller, the significantly immunosuppressed person with autoimmune disease, with specific risks and requirements. This review introduces the concept of the pre-travel risk assessment and discusses the major vaccine-preventable and non-vaccine-preventable travel-associated infections. The challenges and controversies around vaccination and immunosuppression are reviewed with advice for clinical practice.
Medical subject headings
- Autoimmune Diseases
- Communicable Disease Control
- Immunocompromised Host
- Risk Assessment
- Travel-Related Illness
- Vaccine-Preventable Diseases